| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |